Aimmune Therapeutics Inc. (AIMT) Declined -5.76% or -1.74 To Price $28.46 On Thursday


Aimmune Therapeutics Inc. (AIMT) declined -5.76% or -1.74 to $28.46. It is about 449353 shares traded, which is 84.19% compare to the average total volume 533747. The market cap of AIMT is $1.65 billion. The year to date change is -24.99%. The 52 week price range is from $18.25 to $42.0. Price of AIMT have changed 1.41% during last week. It have changed -4.73% over last month, -3.97% over last 3 months, -16.76% over last 6 months and 62.72% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AIMT is 31.17. It is 9.52% above current price. The 200-day Moving Averages for AIMT is 31.90. It is 12.09% above current price. The 52-week High is 42.0. It is 47.58% from the current price. The 52-week Low is 18.25. It is -35.87% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AIMT is 10.52 on 2018-05-31. Short % to float is 8.81%. There are some statistics of AIMT. It is has market cap $1.65 billion. The share outstanding is 58.10 million. The average volume is 533747. The percent of top 15 Institution holding is 91.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AIMT is -52.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AIMT is -48.57%.


Tags:

Share this post